Imported Cutaneous Leishmaniasis

Total Page:16

File Type:pdf, Size:1020Kb

Imported Cutaneous Leishmaniasis Khan et al. Parasites Vectors (2019) 12:527 https://doi.org/10.1186/s13071-019-3771-6 Parasites & Vectors SHORT REPORT Open Access Imported cutaneous leishmaniasis: molecular investigation unveils Leishmania major in Bangladesh Md Anik Ashfaq Khan1, Rajashree Chowdhury1, Rupen Nath1, Sören Hansen2, Progga Nath3, Shomik Maruf1, Ahmed Abd El Wahed2* and Dinesh Mondal1* Abstract Background: The main clinical forms of leishmaniasis in Bangladesh are visceral leishmaniasis and post-kala-azar dermal leishmaniasis, which are caused by Leishmania donovani. Imported cutaneous leishmaniasis (CL) is emerging globally due mainly to increased human mobility. In recent years, several imported CL cases have also been reported in Bangladesh. Sporadic atypical cases of CL can be challenging for diagnosis and clinical management, while occur- rence of infection on a frequent basis can be alarming. We report of a case of a Bangladeshi temporary-migrant worker who, upon return, presented development of skin lesions that are characteristic of CL. Methods: A serum sample was collected and tested with an rK39 immunochromatographic test. Nucleic acid from skin biopsy derived culture sample was extracted and screened with a real-time PCR assay which targets the con- served REPL repeat region of L. donovani complex. The internal transcribed spacer 2 region of the ribosomal RNA gene cluster was amplifed and sequenced. Results: The suspect had a history of travel in both CL and VL endemic areas and had a positive rK39 test result. Based on clinical presentation, travel history and demonstration of the parasite in the skin biopsy, CL was diagnosed and the patient underwent a combination therapy with Miltefosine and liposomal amphotericin B. While typical endemic species were not detected, we identifed Leishmania major, a species that, to our knowledge, has never been reported in Bangladesh. Conclusions: Proper monitoring and reporting of imported cases should be given careful consideration for both clinical and epidemiological reasons. Molecular tests should be performed in diagnosis to avoid dilemma, and identif- cation of causative species should be prioritized. Keywords: Cutaneous leishmaniasis, Bangladesh, Leishmania major, Imported infection, Sequencing Background and visceral (VL) leishmaniasis. Te disease is endemic Leishmaniasis is a group of insidious infectious diseases in many parts of the world. Bangladesh belongs to the caused by species of the protozoan genus Leishmania endemic zones for VL as well as its skin complication transmitted through the bite of sand fies. It is classi- known as post-kala-azar dermal leishmaniasis (PKDL), fed into three clinical forms based upon the afected both of which are caused by Leishmania donovani. A tissue, namely cutaneous (CL), mucocutaneous (MCL) regional initiative for VL elimination, known as the regional kala-azar Elimination Programme (KAEP) have contributed to a remarkable decline in the incidence rate *Correspondence: [email protected]; [email protected] 1 Nutrition and Clinical Services Division, International Centre of VL cases over recent years in Bangladesh and other for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh endemic regions of the Indian subcontinent; it is now 2 Division of Microbiology and Animal Hygiene, Georg-August-Universität approaching the maintenance phase of elimination [1]. Göttingen, Göttingen, Germany Full list of author information is available at the end of the article Patients afected by CL or MCL, on the other hand, are © The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/ publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Khan et al. Parasites Vectors (2019) 12:527 Page 2 of 6 not usually found in Bangladesh, which might be due to he had been in to VL endemic areas of Bangladesh, and the absence of specifc transmitting vectors [2]. Te diag- was found positive by an rK39 rapid immunochromato- nostic and clinical practices are well-defned in the local graphic test (InBios International Inc., Seattle, Washing- health care centres for VL and PKDL, which is not the ton, USA). Te period since the lesion frst appeared was case for CL or MCL. Upon occurrence, the atypical dis- estimated to be three months, when he was working in ease forms may cause diagnostic and clinical dilemmas the Kingdom of Saudi Arabia (KSA), a country known to with respect to clinical presentation, cross-reaction in be endemic for CL. Physical examination revealed one serological tests, and treatment strategies [3, 4]. System- central depigmented ulcerated region surrounded by atic investigation of atypical cases and identifcation of several hyperkeratotic, plaque like, sharply demarcated, the causative Leishmania species are also important for painless papulonodular lesions (Fig. 1a) on his distal epidemiological reasons. Here, we report of a temporary- posteromedial aspect of the left forearm. Based on case migrant worker who was diagnosed with CL after his history and clinical examination, a provisional diagno- return to Bangladesh. We identifed L. major as the caus- sis of CL was made and lesional biopsy was obtained for ative agent. To our knowledge, this is the frst report of a parasitological confrmation. Maintaining aseptic con- L. major infected CL case in Bangladesh. ditions, a ~ 3.0 mm in diameter skin snip was collected with a scalpel from the nodular lesions followed by direct Methods microscopy of the Giemsa-stained thin biopsy smear, Case presentation which revealed large macrophages containing abundant A 40-year-old male was referred from the M.A.G Osmani intracellular and extracellular amastigotes (3+ para- Medical College Hospital, Sylhet to the Surya Kanta Kala- sitemia grade: 1–10 parasites/microscopic feld). One azar Research Center (SKKRC) hospital, Mymensingh in additional snip of a nodular lesion as well as pictures of October 2017 as a suspected case of CL, with multiple the lesions were collected following the patient’s consent. skin lesions on his left forearm. However, no other anom- Te patient received a combination therapy of liposo- aly such as fever, hepato-splenomegaly or mucosal lesion mal amphotericin B (AmBisome) at a dose of 20 mg/kg was observed. Te patient had no history of VL, although body-weight in four equally divided doses for four days. Fig. 1 Ulcerative lesion surrounded by nodules on the lower left arm of the patient, October 2017 to January 2018, SKKRC hospital, Mymensingh before treatment (a), fve days after treatment with 4 doses of AmBisome (b) and twelve weeks after treatment with Miltefosine (c) Khan et al. Parasites Vectors (2019) 12:527 Page 3 of 6 Tis was followed by an oral Miltefosine capsule for 12 sequences for Leishmania spp. with GENEIOUS v.9.1.6 weeks at a dose of 100 mg/day. Te combination therapy (Biomatters Ltd., Auckland, New Zealand) using the resulted in a remarkable improvement, demonstrated incorporated tree builder at default settings. by the dried up nodular crusts after fve days (Fig. 1b), and disappearance of nodules leaving atrophic scars Results with hypopigmented spots in the middle after 12 weeks Te RT-PCR assay did not result in a positive detection of (Fig. 1c). No major side-efect was reported during the L. donovani DNA in the culture sample. For identifcation follow-up visits and the patient did not return with any of Leishmania species, therefore, the PCR amplifed 400- relapse symptoms. bp segment of ITS2 spacer was sequenced. Te obtained sequence (Leish 17-832), which was assigned for species Parasite culture and DNA extraction identifcation using nucleotide BLAST search (NCBI), showed pairwise similarity of 99% to L. major reference Te additional skin snip (~ 3.0 mm in diameter) col- genome (GenBank: NC_007268) with a query cover of lected from a nodular lesion was inoculated into RPMI- 100%. In contrast, for the closest reference genome strain 1640 culture medium with 10% FBS supplemented with of L. infantum (GenBank: NW_004057905.1), the pair- penicillin-streptomycin. Two volumes each of stationary wise identity and query cover was 88% and 90%, respec- phase culture promastigotes were inactivated, stored in tively (Table 1). Te phylogenetic tree constructed for the bufer AL (Qiagen) at a 1:1 ratio and sent to the Emerging obtained ITS2 sequence showed that L. major, originat- Infections and Parasitology laboratory of International ing possibly from Iran, shares a common ancestral node Center for Diarrheal Disease Research (Dhaka, Bangla- with the test sequence in a single branch (Fig. 2). Te desh). DNA was extracted by using a QIAmp Blood DNA obtained nucleotide sequence was submitted to the Gen- Mini Kit (Qiagen). Bank database under the accession no. MK034756. Real‑time PCR and sequencing Discussion A TaqMan probe based real-time (RT)-PCR assay, In Bangladesh, VL and PKDL are prevalent in endemic which targets the conserved region of Leishmania REPL areas, whereas CL, a localized manifestation of nodu- repeats (L42486.1) of L. donovani complex, was carried lar or popular lesion with ulceration, is not regarded
Recommended publications
  • Regulatory Mechanisms of Leishmania Aquaglyceroporin AQP1 Mansi Sharma Florida International University, [email protected]
    Florida International University FIU Digital Commons FIU Electronic Theses and Dissertations University Graduate School 11-6-2015 Regulatory mechanisms of Leishmania Aquaglyceroporin AQP1 Mansi Sharma Florida International University, [email protected] DOI: 10.25148/etd.FIDC000197 Follow this and additional works at: https://digitalcommons.fiu.edu/etd Part of the Parasitology Commons Recommended Citation Sharma, Mansi, "Regulatory mechanisms of Leishmania Aquaglyceroporin AQP1" (2015). FIU Electronic Theses and Dissertations. 2300. https://digitalcommons.fiu.edu/etd/2300 This work is brought to you for free and open access by the University Graduate School at FIU Digital Commons. It has been accepted for inclusion in FIU Electronic Theses and Dissertations by an authorized administrator of FIU Digital Commons. For more information, please contact [email protected]. FLORIDA INTERNATIONAL UNIVERSITY Miami, Florida REGULATORY MECHANISMS OF LEISHMANIA AQUAGLYCEROPORIN AQP1 A dissertation submitted in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in BIOLOGY by Mansi Sharma 2015 To: Dean Michael R. Heithaus College of Arts and Sciences This dissertation, written by Mansi Sharma, and entitled, Regulatory Mechanisms of Leishmania Aquaglyceroporin AQP1, having been approved in respect to style and intellectual content, is referred to you for judgment. We have read this dissertation and recommend that it be approved. _______________________________________ Lidia Kos _____________________________________ Kathleen
    [Show full text]
  • Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity
    microorganisms Review Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity John M. Curtin 1,2,* and Naomi E. Aronson 2 1 Infectious Diseases Service, Walter Reed National Military Medical Center, Bethesda, MD 20814, USA 2 Infectious Diseases Division, Uniformed Services University, Bethesda, MD 20814, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-011-301-295-6400 Abstract: Leishmaniasis, a chronic and persistent intracellular protozoal infection caused by many different species within the genus Leishmania, is an unfamiliar disease to most North American providers. Clinical presentations may include asymptomatic and symptomatic visceral leishmaniasis (so-called Kala-azar), as well as cutaneous or mucosal disease. Although cutaneous leishmaniasis (caused by Leishmania mexicana in the United States) is endemic in some southwest states, other causes for concern include reactivation of imported visceral leishmaniasis remotely in time from the initial infection, and the possible long-term complications of chronic inflammation from asymptomatic infection. Climate change, the identification of competent vectors and reservoirs, a highly mobile populace, significant population groups with proven exposure history, HIV, and widespread use of immunosuppressive medications and organ transplant all create the potential for increased frequency of leishmaniasis in the U.S. Together, these factors could contribute to leishmaniasis emerging as a health threat in the U.S., including the possibility of sustained autochthonous spread of newly introduced visceral disease. We summarize recent data examining the epidemiology and major risk factors for acquisition of cutaneous and visceral leishmaniasis, with a special focus on Citation: Curtin, J.M.; Aronson, N.E.
    [Show full text]
  • Identification of Leishmania Donovani Inhibitors from Pathogen Box Compounds of Medicine for Malaria Venture
    bioRxiv preprint doi: https://doi.org/10.1101/716134; this version posted July 26, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Identification of Leishmania donovani inhibitors from pathogen box compounds of Medicine for Malaria Venture Markos Tadele1¶, Solomon M. Abay2¶*, Eyasu Makonnen2,4, Asrat Hailu3 1 Ethiopian institute of agricultural research, Animal health research program, Holetta, Ethiopia 2Department of Pharmacology and clinical pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia 3Department of Microbiology, Immunology and Parasitology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia 4Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT Africa), College of Health Sciences, Addis Ababa University * Corresponding author Email: [email protected], [email protected] ¶ These authors contributed equally to this work. Author Contributions Conceptualization and design the experiment: MT, SMA, EM, AH Investigation: MT, SMA, AH Data analysis: MT, SMA Funding acquisition and reagents contribution: SMA, AH Supervision: SMA, EM, AH Writing – original draft: MT Writing – review & editing: MT, SMA, EM, AH 1 | P a g e bioRxiv preprint doi: https://doi.org/10.1101/716134; this version posted July 26, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license.
    [Show full text]
  • Catalogue of Protozoan Parasites Recorded in Australia Peter J. O
    1 CATALOGUE OF PROTOZOAN PARASITES RECORDED IN AUSTRALIA PETER J. O’DONOGHUE & ROBERT D. ADLARD O’Donoghue, P.J. & Adlard, R.D. 2000 02 29: Catalogue of protozoan parasites recorded in Australia. Memoirs of the Queensland Museum 45(1):1-164. Brisbane. ISSN 0079-8835. Published reports of protozoan species from Australian animals have been compiled into a host- parasite checklist, a parasite-host checklist and a cross-referenced bibliography. Protozoa listed include parasites, commensals and symbionts but free-living species have been excluded. Over 590 protozoan species are listed including amoebae, flagellates, ciliates and ‘sporozoa’ (the latter comprising apicomplexans, microsporans, myxozoans, haplosporidians and paramyxeans). Organisms are recorded in association with some 520 hosts including mammals, marsupials, birds, reptiles, amphibians, fish and invertebrates. Information has been abstracted from over 1,270 scientific publications predating 1999 and all records include taxonomic authorities, synonyms, common names, sites of infection within hosts and geographic locations. Protozoa, parasite checklist, host checklist, bibliography, Australia. Peter J. O’Donoghue, Department of Microbiology and Parasitology, The University of Queensland, St Lucia 4072, Australia; Robert D. Adlard, Protozoa Section, Queensland Museum, PO Box 3300, South Brisbane 4101, Australia; 31 January 2000. CONTENTS the literature for reports relevant to contemporary studies. Such problems could be avoided if all previous HOST-PARASITE CHECKLIST 5 records were consolidated into a single database. Most Mammals 5 researchers currently avail themselves of various Reptiles 21 electronic database and abstracting services but none Amphibians 26 include literature published earlier than 1985 and not all Birds 34 journal titles are covered in their databases. Fish 44 Invertebrates 54 Several catalogues of parasites in Australian PARASITE-HOST CHECKLIST 63 hosts have previously been published.
    [Show full text]
  • Leishmania Species
    APPENDIX 2 Leishmania Species • Fewer than 15 probable or confirmed cases of trans- mission by blood transfusion and 10 reported cases of Disease Agent: congenital transmission worldwide • Leishmania species At-Risk Populations: Disease Agent Characteristics: • Residents of and travelers to endemic areas Vector and Reservoir Involved: • Protozoan, 2.5 ¥ 5.0 mm • Order: Kinetoplastida • Phlebotomine sandflies: Phlebotomus genus (Old • Family: Trypanosomatidae World) and Lutzomyia genus (New World) • Intracellular pathogen of macrophages/monocytes • Only the amastigote stage is found in humans. Blood Phase: • Leishmania parasites survive and multiply in mono- Disease Name: nuclear phagocytes. Parasite circulation in peripheral • Leishmaniasis blood has been reported in asymptomatic L. dono- • Visceral leishmaniasis is called kala-azar in India and vani, L. tropica, and L. infantum infections, and in various names elsewhere. treated and inapparent L. braziliensis infections. • Cutaneous forms have a variety of colloquial names Survival/Persistence in Blood Products: around the world. • Leishmania species are known to survive in human Priority Level: RBCs under blood bank storage conditions for as long as 15 days and longer in experimental animal models. • Scientific/Epidemiologic evidence regarding blood safety: Low Transmission by Blood Transfusion: • Public perception and/or regulatory concern regard- ing blood safety: Low • Transfusion transmission has been documented in at • Public concern regarding disease agent: Low, but least three cases
    [Show full text]
  • New Tools and Knowledge to Reduce Bottlenecks in Drug Discovery
    G C A T T A C G G C A T genes Review Of Drugs and Trypanosomatids: New Tools and Knowledge to Reduce Bottlenecks in Drug Discovery Arijit Bhattacharya 1 , Audrey Corbeil 2, Rubens L. do Monte-Neto 3 and Christopher Fernandez-Prada 2,* 1 Department of Microbiology, Adamas University, Kolkata, West Bengal 700 126, India; [email protected] 2 Department of Pathology and Microbiology, Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, QC J2S 2M2, Canada; [email protected] 3 Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte MG 30190-009, Brazil; rubens.monte@fiocruz.br * Correspondence: [email protected]; Tel.: +1-450-773-8521 (ext. 32802) Received: 4 June 2020; Accepted: 26 June 2020; Published: 29 June 2020 Abstract: Leishmaniasis (Leishmania species), sleeping sickness (Trypanosoma brucei), and Chagas disease (Trypanosoma cruzi) are devastating and globally spread diseases caused by trypanosomatid parasites. At present, drugs for treating trypanosomatid diseases are far from ideal due to host toxicity, elevated cost, limited access, and increasing rates of drug resistance. Technological advances in parasitology, chemistry, and genomics have unlocked new possibilities for novel drug concepts and compound screening technologies that were previously inaccessible. In this perspective, we discuss current models used in drug-discovery cascades targeting trypanosomatids (from in vitro to in vivo approaches), their use and limitations in a biological context, as well as different
    [Show full text]
  • Modeling Post-Kala-Azar Dermal
    ⃝c REVISTA DE MATEMÁTICA:TEORÍA Y APLICACIONES 2020 27(1) : 221–239 CIMPA – UCR ISSN: 1409-2433 (PRINT), 2215-3373 (ONLINE) DOI: https://doi.org/10.15517/rmta.v27i1.39973 MODELING POST-KALA-AZAR DERMAL LEISHMANIASIS AS AN INFECTION RESERVOIR FOR VISCERAL LEISHMANIASIS LEISHMANIASIS DÉRMICA POST-KALA-AZAR COMO RESERVORIO DE INFECCIÓN PARA LA LEISHMANIASIS VISCERAL ∗ y z ANDREA CALDERON RYAN LANDRITH NHAN LE { ILEANA MUÑOZ§ CHRISTOPHER M. KRIBS Received: 16/May/2019; Revised: 6/Jun/2019; Accepted: 13/Sep/2019 ∗University of Texas at Arlington, Department of Biology, Arlington TX, United States. E- Mail: [email protected] yMisma dirección que/Same address as: A Calderon. E-Mail: [email protected] zUniversity of Texas at Arlington, Department of Computer Science and Engineering, Arling- ton TX, United States. E-Mail: [email protected] §University of Texas at Arlington, Department of Mathematics, Arlington TX, United States. E-Mail: [email protected] {University of Texas at Arlington, Departments of Mathematics and Curriculum & Instruction, Arlington TX, United States. E-Mail: [email protected] 221 222 A. CALDERON – R. LANDRITH – N. LE – I. MUÑOZ – C. KRIBS Abstract Visceral Leishmaniasis (VL) is a potentially fatal disease caused by the protozoan parasite Leishmania donovani. This disease is a health problem for the very poor because it results in thousands of deaths and illnesses every year. Some countries, such as India and Bangladesh, have started programs to reduce the occurrences of VL by focusing on early diagno- sis and complete treatment of VL. Post-Kala-azar Dermal Leishmaniasis (PKDL) is a cutaneous manifestation of Leishmaniasis that can occur fol- lowing the incomplete treatment of VL.
    [Show full text]
  • CHECKLIST of PROTOZOA RECORDED in AUSTRALASIA O'donoghue P.J. 1986
    1 PROTOZOAN PARASITES IN ANIMALS Abbreviations KINGDOM PHYLUM CLASS ORDER CODE Protista Sarcomastigophora Phytomastigophorea Dinoflagellida PHY:din Euglenida PHY:eug Zoomastigophorea Kinetoplastida ZOO:kin Proteromonadida ZOO:pro Retortamonadida ZOO:ret Diplomonadida ZOO:dip Pyrsonymphida ZOO:pyr Trichomonadida ZOO:tri Hypermastigida ZOO:hyp Opalinatea Opalinida OPA:opa Lobosea Amoebida LOB:amo Acanthopodida LOB:aca Leptomyxida LOB:lep Heterolobosea Schizopyrenida HET:sch Apicomplexa Gregarinia Neogregarinida GRE:neo Eugregarinida GRE:eug Coccidia Adeleida COC:ade Eimeriida COC:eim Haematozoa Haemosporida HEM:hae Piroplasmida HEM:pir Microspora Microsporea Microsporida MIC:mic Myxozoa Myxosporea Bivalvulida MYX:biv Multivalvulida MYX:mul Actinosporea Actinomyxida ACT:act Haplosporidia Haplosporea Haplosporida HAP:hap Paramyxea Marteilidea Marteilida MAR:mar Ciliophora Spirotrichea Clevelandellida SPI:cle Litostomatea Pleurostomatida LIT:ple Vestibulifera LIT:ves Entodiniomorphida LIT:ent Phyllopharyngea Cyrtophorida PHY:cyr Endogenida PHY:end Exogenida PHY:exo Oligohymenophorea Hymenostomatida OLI:hym Scuticociliatida OLI:scu Sessilida OLI:ses Mobilida OLI:mob Apostomatia OLI:apo Uncertain status UNC:sta References O’Donoghue P.J. & Adlard R.D. 2000. Catalogue of protozoan parasites recorded in Australia. Mem. Qld. Mus. 45:1-163. 2 HOST-PARASITE CHECKLIST Class: MAMMALIA [mammals] Subclass: EUTHERIA [placental mammals] Order: PRIMATES [prosimians and simians] Suborder: SIMIAE [monkeys, apes, man] Family: HOMINIDAE [man] Homo sapiens Linnaeus,
    [Show full text]
  • WO 2016/033635 Al 10 March 2016 (10.03.2016) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2016/033635 Al 10 March 2016 (10.03.2016) P O P C T (51) International Patent Classification: AN, Martine; Epichem Pty Ltd, Murdoch University Cam Λ 61Κ 31/155 (2006.01) C07D 249/14 (2006.01) pus, 70 South Street, Murdoch, Western Australia 6150 A61K 31/4045 (2006.01) C07D 407/12 (2006.01) (AU). ABRAHAM, Rebecca; School of Animal and A61K 31/4192 (2006.01) C07D 403/12 (2006.01) Veterinary Science, The University of Adelaide, Adelaide, A61K 31/341 (2006.01) C07D 409/12 (2006.01) South Australia 5005 (AU). A61K 31/381 (2006.01) C07D 401/12 (2006.01) (74) Agent: WRAYS; Groud Floor, 56 Ord Street, West Perth, A61K 31/498 (2006.01) C07D 241/20 (2006.01) Western Australia 6005 (AU). A61K 31/44 (2006.01) C07C 211/27 (2006.01) A61K 31/137 (2006.01) C07C 275/68 (2006.01) (81) Designated States (unless otherwise indicated, for every C07C 279/02 (2006.01) C07C 251/24 (2006.01) kind of national protection available): AE, AG, AL, AM, C07C 241/04 (2006.01) A61P 33/02 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, C07C 281/08 (2006.01) A61P 33/04 (2006.01) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, C07C 337/08 (2006.01) A61P 33/06 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, C07C 281/18 (2006.01) HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, (21) International Application Number: MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PCT/AU20 15/000527 PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, (22) International Filing Date: SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, 28 August 2015 (28.08.2015) TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • The Absence of C-5 DNA Methylation in Leishmania Donovani Allows DNA Enrichment from Complex Samples
    microorganisms Article The Absence of C-5 DNA Methylation in Leishmania donovani Allows DNA Enrichment from Complex Samples 1,2, 1, , 2 2 Bart Cuypers y, Franck Dumetz y z , Pieter Meysman , Kris Laukens , Géraldine De Muylder 1, Jean-Claude Dujardin 1,3 and Malgorzata Anna Domagalska 1,* 1 Molecular Parasitology, Institute of Tropical Medicine, 2000 Antwerp, Belgium; [email protected] (B.C.); [email protected] (F.D.); [email protected] (J.-C.D.) 2 ADReM Data Lab, Department of Computer Science, University of Antwerp, 2000 Antwerp, Belgium; [email protected] (P.M.); [email protected] (K.L.) 3 Department of Biomedical Sciences, University of Antwerp, 2000 Antwerp, Belgium * Correspondence: [email protected] These authors contributed equally to this work. y Present address: Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK. z Received: 11 July 2020; Accepted: 12 August 2020; Published: 18 August 2020 Abstract: Cytosine C5 methylation is an important epigenetic control mechanism in a wide array of eukaryotic organisms and generally carried out by proteins of the C-5 DNA methyltransferase family (DNMTs). In several protozoans, the status of this mechanism remains elusive, such as in Leishmania, the causative agent of the disease leishmaniasis in humans and a wide array of vertebrate animals. In this work, we showed that the Leishmania donovani genome contains a C-5 DNA methyltransferase (DNMT) from the DNMT6 subfamily, whose function is still unclear, and verified its expression at the RNA level. We created viable overexpressor and knock-out lines of this enzyme and characterized their genome-wide methylation patterns using whole-genome bisulfite sequencing, together with promastigote and amastigote control lines.
    [Show full text]
  • Current Perspectives on Leishmaniasis
    Editorial | Reddy KR. Current Perspectives on Leishmaniasis Current Perspectives on Leishmaniasis Reddy KR Professor & Head Microbiology Department Gandaki Medical College & Teaching Hospital, Pokhara, Nepal Sir William Boog Leishman Leishmania donovani parasite in spleen smear of English soldier from London, who died of Dum Dum fever or kala first demonstrated azar Sir Donovan contracted at Dum-Dum in Kolkata, India, in 1903. In the same year, Leishmania donovani also reported the same parasite in spleen smear of a patient from Madras (Chennai), TheirIndia. Thesimultaneous name discovery of Leishmania was therefore donovani given firstto this alerted parasite. the scientific community to the life threatening disease of visceral Leishmania Journal of leishmaniasis. Now a century later, millions are still afflicted by . It is a disease known for its complexity and diversity. It is endemic in regions ranging from the rainforests of South America GANDAKI 21 different species of Leishmania to the deserts of Asia, and afflicts both rural and urban communities. A host of about cutaneous, mucocutaneos and visceral, which result from parasite multiplication in MEDICAL are classified under its primary syndromes; COLLEGE- phlebotomine sand flies. macrophages in the skin, nasal-oral mucosa and internal organs, respectively. These Charles Nicolle, a 1928 Nobel laureate, at the Pasteur Institute of Tunis, characterized protozoan species are transmitted by over 30 species of NEPAL the (J-GMC-N) Whilenew most World modes visceral of leishmaniasistransmission andare cultivatedvector borne, the etiologic some areagent. congenital and J-GMC-N | Volume 12| Issue 01| increases in travel and international migration have brought this disease to the January-June 2019 parenteral (i.e.
    [Show full text]
  • Insights Into Leishmania Molecules and Their Potential Contribution to the Virulence of the Parasite
    veterinary sciences Review Insights into Leishmania Molecules and Their Potential Contribution to the Virulence of the Parasite Ehab Kotb Elmahallawy 1,* and Abdulsalam A. M. Alkhaldi 2,* 1 Department of Zoonoses, Faculty of Veterinary Medicine, Sohag University, Sohag 82524, Egypt 2 Biology Department, College of Science, Jouf University, Sakaka, Aljouf 2014, Saudi Arabia * Correspondence: [email protected] (E.K.E.); [email protected] (A.A.M.A.) Abstract: Neglected parasitic diseases affect millions of people worldwide, resulting in high mor- bidity and mortality. Among other parasitic diseases, leishmaniasis remains an important public health problem caused by the protozoa of the genus Leishmania, transmitted by the bite of the female sand fly. The disease has also been linked to tropical and subtropical regions, in addition to being an endemic disease in many areas around the world, including the Mediterranean basin and South America. Although recent years have witnessed marked advances in Leishmania-related research in various directions, many issues have yet to be elucidated. The intention of the present review is to give an overview of the major virulence factors contributing to the pathogenicity of the parasite. We aimed to provide a concise picture of the factors influencing the reaction of the parasite in its host that might help to develop novel chemotherapeutic and vaccine strategies. Keywords: Leishmania; parasite; virulence; factors Citation: Elmahallawy, E.K.; Alkhaldi, A.A.M. Insights into 1. Introduction Leishmania Molecules and Their Leishmaniasis is a group of neglected tropical diseases caused by an opportunistic Potential Contribution to the intracellular protozoan organism of the genus Leishmania that affects people, domestic Virulence of the Parasite.
    [Show full text]